Terumo Aortic Global Endovascular Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorVascutek Ltd.
About this trial
Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.
Eligibility criteria
Qualifiers
Minimum age as per local regulations
Indication for aortic endovascular repair with an approved or CE marked by a Regulatory body or custom-made Terumo Aortic Endovascular graft
Ability to provide informed consent
Willingness to comply with the registry protocol
Disqualifiers
None
Trial design
Treatments tested in this trial
- Thoracic
- Abdominal
- Custom Device
- Illiac Artery
Treatment groups
1,000 Participants
are divided into 4 treatment groupsSponsors and collaborators
Vascutek Ltd.
Lead sponsor
Bolton Medical
Collaborator
Source ClinicalTrials.gov